This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Epidemiology of psoriasis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Epidemiology

  • Psoriasis is universal in occurrence (1), affecting males and females equally
  • Prevalence varies with race and geography
    • it is greatest in regions with older populations and lowest in those with younger populations (2)
    • around 2% of the population in the UK is affected by psoriasis with the highest prevalence in white adults (1)

  • there is a clear genetic link established by HLA, family and twin studies, especially in those whose disease had an early onset and in patients with a positive family history (3)

  • according to a number of large studies a bimodal age of onset has been documented with the first peak from 15-20 years and the second at 55 -60 years (2)
    • onset is most common between 15-40 years of age. It is rare under 10 years. The mean is 28 years
    • a seronegative arthropathy occurs in about 7% of patients


  • NICE suggest (1):
    • is uncommon in children (0.71%) and the majority of cases occur before 35 years
      • plaque psoriasis is characterised by well-delineated red, scaly plaques that vary in extent from a few patches to generalised involvement
        • by far the most common form of the condition (about 90% of people with psoriasis)
        • other types of psoriasis include guttate psoriasis and pustular (localised or generalised) forms
      • distinctive nail changes occur in around 50% of all those affected and are more common in people with psoriatic arthritis
    • several studies have also reported that people with psoriasis, particularly those with severe disease, may be at increased risk of cardiovascular disease, lymphoma and non-melanoma skin cancer (4) (5)

Reference:

1. Psoriasis: The assessment and management of psoriasis. NICE Clinical Guideline (October 2012 - last updated September 2017)

2. Parisi R et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020 May 28;369:m1590.

3. Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2005 May

4. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013 Apr;68(4):654-62.

5. Gelfand JM et al. The risk of lymphoma in patients with psoriasis. J Invest Dermatol. 2006 Oct;126(10):2194-201.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.